Latest Health News

Tag: federal-trade

  • Bayer’s Monsanto acquisition to face politically charged scrutiny

    —

    by

    elegant
    in

    By Diane Bartz and Greg Roumeliotis WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Bayer’s pesticide-focused agricultural business has few overlaps…

  • Bayer’s Monsanto acquisition to face politically charged scrutiny

    —

    by

    elegant
    in

    By Diane Bartz and Greg Roumeliotis WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Bayer’s pesticide-focused agricultural business has few overlaps…

  • Bayer clinches Monsanto with improved $66 billion bid

    —

    by

    publisher
    in

    NEW YORK/FRANKFURT (Reuters) – German drug and crop chemical maker Bayer clinched a $66 billion takeover of U.S. seeds company Monsanto on Wednesday, ending months of wrangling with a third sweetened offer that marks the largest all-cash deal on record. The $128-a-share deal, up from Bayer's previous offer of $127.50 a share, has emerged as…

  • Bayer clinches Monsanto with improved $66 billion bid

    —

    by

    creative
    in

    NEW YORK/FRANKFURT (Reuters) – German drug and crop chemical maker Bayer clinched a $66 billion takeover of U.S. seeds company Monsanto on Wednesday, ending months of wrangling with a third sweetened offer that marks the largest all-cash deal on record. The $128-a-share deal, up from Bayer's previous offer of $127.50 a share, has emerged as…

  • U.S. lawmakers press Mylan on EpiPen price increases

    —

    by

    publisher
    in

    Two senior lawmakers on the U.S. Senate’s Judiciary Committee on Monday pushed for information regarding sharp price increases for EpiPens, drug-filled injectable devices used by people to counter potentially deadly allergic reactions. Senator Chuck Grassley, chairman of the Senate Judiciary Committee, wrote Mylan Chief Executive Heather Bresch on Monday to ask how Mylan determined the…

  • Teva, Allergan win U.S. antitrust approval for generics deal

    —

    by

    contributor
    in

    WASHINGTON (Reuters) – Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said on Wednesday.